A phase I trial of CCL21 gene modified dendritic cells in non-small cell lung cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Lung cancer vaccine (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 03 Aug 2020 Biomarkers information updated
- 11 Jul 2013 Planned end date changed from 1 Sep 2013 to 1 Oct 2013 as reported by ClinicalTrials.gov.
- 11 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.